Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buddy Creech

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Hospital Pediatrics|January 5, 2023
Using Administrative Billing Codes to Identify Acute Musculoskeletal Infections in ChildrenJustin B Searns, John D Rice, Kaitlyn B Bertin, et al.
Vaccine|November 22, 2016
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trialC Buddy Creech, Robert W Frenck, Eric A Sheldon, et al.
The Journal of Infectious Diseases|August 18, 2011
Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young childrenDaniel F Hoft, Elizabeth Babusis, Shewangizaw Worku, et al.
Cell Host & Microbe|November 24, 2019
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in MiceIuliia M Gilchuk, Sandhya Bangaru, Pavlo Gilchuk, et al.
Plos One|January 19, 2017
Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled TrialLeigh M Howard, Kristen L Hoek, Johannes B Goll, et al.
The Journal of Infectious Diseases|September 30, 2024
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic FibrosisStephanie L Rolsma, Andrew Sokolow, Pratish C Patel, et al.
The Journal of Infectious Diseases|March 6, 2022
Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired PneumoniaJiye Kwon, Yong Kong, Martina Wade, et al.
Vaccine|December 15, 2015
Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccineInnocent N Mbawuike, Robert L Atmar, Shital M Patel, et al.
NPJ Vaccines|August 11, 2025
Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccinesC Buddy Creech, Mariana Leguia, Johannes B Goll, et al.
Plos One|November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trialKatherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Hospital Pediatrics|January 5, 2023
Using Administrative Billing Codes to Identify Acute Musculoskeletal Infections in ChildrenJustin B Searns, John D Rice, Kaitlyn B Bertin, et al.
Vaccine|November 22, 2016
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trialC Buddy Creech, Robert W Frenck, Eric A Sheldon, et al.
The Journal of Infectious Diseases|August 18, 2011
Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young childrenDaniel F Hoft, Elizabeth Babusis, Shewangizaw Worku, et al.
Cell Host & Microbe|November 24, 2019
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in MiceIuliia M Gilchuk, Sandhya Bangaru, Pavlo Gilchuk, et al.
Plos One|January 19, 2017
Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled TrialLeigh M Howard, Kristen L Hoek, Johannes B Goll, et al.
The Journal of Infectious Diseases|September 30, 2024
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic FibrosisStephanie L Rolsma, Andrew Sokolow, Pratish C Patel, et al.
The Journal of Infectious Diseases|March 6, 2022
Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired PneumoniaJiye Kwon, Yong Kong, Martina Wade, et al.
Vaccine|December 15, 2015
Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccineInnocent N Mbawuike, Robert L Atmar, Shital M Patel, et al.
NPJ Vaccines|August 11, 2025
Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccinesC Buddy Creech, Mariana Leguia, Johannes B Goll, et al.
Plos One|November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trialKatherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.
Pageof 14